An editor in his early 40s thought the tiny numb spot on his nose was innocuous. A year and six doctors later, he learned it ...

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

PORT ANGELES — Dr. Allen Chen didn’t originally apply for the position of chief physician officer at Olympic Medical Center.

Chemoablation with mitomycin gel (Jelmyto) for low-grade upper tract urothelial cancer led to a 3-year recurrence-free ...

Oncology practices at Olean General Hospital's Barry Street Health Center and at Bradford Regional Medical Center have received recertification by the Association for Clinical Oncology, an affiliate o ...

The State-run Kidwai Memorial Institute of Oncology (KMIO) achieved a milestone by successfully completing 1,000 robotic ...

Conversion therapy has become a hot topic among specialists in gastrointestinal cancers, said Pamela Kunz, MD, of the Yale ...

Radiation oncologists at UH Seidman Cancer Center have another powerful treatment option for patients diagnosed with many forms of cancer with the addition of Varian Ethos 2.0, capable of a new form ...

AbbVie and Neomorph are forming a partnership and option-to-license agreement to develop molecular glue degraders, aiming to ...

BENGALURU: Kidwai Memorial Institute of Oncology (KMIO), the first government hospital in the state to adopt robotic ...

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...